- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07310004
Virtual Reality vs. Music Relaxation for Reducing Anxiety and Pain During Breast Biopsies
February 3, 2026 updated by: Jonsson Comprehensive Cancer Center
This study aims to compare the effectiveness of a Virtual Reality (VR) application computer simulation [(CS) VR Mindful Meditation App')] versus music relaxation in reducing anxiety and pain in women undergoing breast biopsies.
Participants will be randomized into three groups: VR, music relaxation, or standard care.
Anxiety and pain will be measured using validated scales, and an optional physiological marker may be collected to assess stress levels.
Participants will also be asked about their satisfaction with the intervention received, along with procedure-specific questions.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
600
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Taylor L Johnson
- Phone Number: 310-889-4607
- Email: taylorjohnson@mednet.ucla.edu
Study Contact Backup
- Name: Antonia Petruse
- Email: apetruse@mednet.ucla.edu
Study Locations
-
-
California
-
Los Angeles, California, United States, 90095
- Recruiting
- Westwood
-
Contact:
- Taylor L Johnson
- Phone Number: 310-889-4607
- Email: taylorjohnson@mednet.ucla.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Females aged 18 years or older.
- Scheduled for an ultrasound-guided or stereotactic breast biopsy.
- Capable of understanding and providing informed consent.
Exclusion Criteria:
- Individuals with a history of epilepsy, motion sickness, or severe cognitive impairment (for the VR group).
- Use of anxiolytic medication immediately prior to the biopsy.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: VR Intervention
Patients will wear a Virtual Reality (VR) headset during the breast biopsy.
They will use the CS VR Mindful Meditation App.
Anxiety and pain will be measured using validated scales, and an optional physiological marker may be collected to assess stress levels.
Participants will also be asked about their satisfaction with the intervention received, along with procedure-specific questions.
|
Patients will wear a Virtual Reality (VR) headset and use an application called CS VR Mindful Meditation App.
|
|
Active Comparator: Music Intervention
Patients will listen to standard calming music during the breast biopsy from the computer/speakers in the room.
Anxiety and pain will be measured using validated scales, and an optional physiological marker may be collected to assess stress levels.
Participants will also be asked about their satisfaction with the intervention received, along with procedure-specific questions.
|
Patients will listen to standard calming music played in the room.
|
|
No Intervention: No Intervention
Patients will have no intervention and complete the breast biopsy as standard of care.
Anxiety and pain will be measured using validated scales, and an optional physiological marker may be collected to assess stress levels.
Participants will also be asked about their satisfaction with the intervention received, along with procedure-specific questions.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Anxiety
Time Frame: perioperatively/periprocedurally
|
Pre- and post-procedure anxiety will be measured using the State-Trait Anxiety Inventory (STAI).
The scale uses a four point Likert scale ranging from "not at all" to "very much so."
The score range is from 20-80 with a higher score indicating more anxiety.
The change in anxiety scores (pre- to post-procedure) will be compared across the three groups (VR, music relaxation, and control).
|
perioperatively/periprocedurally
|
|
Pain Level
Time Frame: perioperatively/periprocedurally
|
Pain will be measured using the Visual Analog Scale (VAS) before and after the procedure.
The scale is a subjective measure where individuals mark pain intensity on a 100mm line.
typically from "no pain" (0) to "wort possible pain" (100).
Higher score is worse.
The change in pain scores (pre- to post-procedure) will be analyzed.
The
|
perioperatively/periprocedurally
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Physiological Markers
Time Frame: During Biopsy
|
Heart Rate Variability (RR intervals) may be recorded during the biopsy as an objective marker of anxiety and stress.
This will be an optional measure and will require the patient to wear either a Polar H10 Heart Rate Sensor below the breast or a Heart Rate Sensor on the arm during the procedure.
|
During Biopsy
|
|
Satisfaction Scores
Time Frame: immediately after the intervention/procedure/surgery
|
For participants in the VR and music relaxation groups, a 5-point Likert scale will measure their satisfaction with the intervention.
The "Intervention Satisfaction Question" asks "How satisfied were you with the intervention you received?", with 1 being "Not at all satisfied" and 5 being "Extremely satisfied".
In this scale, a higher score means a better outcome.
There is also the option for "I received no intervention."
|
immediately after the intervention/procedure/surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 20, 2026
Primary Completion (Estimated)
June 1, 2027
Study Completion (Estimated)
December 1, 2027
Study Registration Dates
First Submitted
February 19, 2025
First Submitted That Met QC Criteria
December 15, 2025
First Posted (Actual)
December 30, 2025
Study Record Updates
Last Update Posted (Actual)
February 5, 2026
Last Update Submitted That Met QC Criteria
February 3, 2026
Last Verified
January 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 24-6080
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain
-
Boston Scientific CorporationRecruitingLow Back Pain | Chronic Pain | Chronic Low-back Pain | Leg Pain | Intractable Pain | Chronic Leg PainUnited States
-
Qi's ClinicNot yet recruitingNon-Cancer Pain,Musculoskeletal Pain,Chronic Pain,Acute Pain
-
Flowonix MedicalApproved for marketingBack Pain | Leg Pain | Trunk Pain | Intractable Pain | Arm Pain
-
George Washington UniversityRecruitingCervical Fusion | Pain, Back | Pain, Neck | Myofacial PainUnited States
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Postoperative Pain, Acute | Postoperative Pain, Chronic | VATSTurkey
-
Janssen Research & Development, LLCCompletedPain, Radiating | Pain, Burning | Pain, Crushing | Pain, Migratory | Pain, SplittingUnited States, France, Spain, Poland, Portugal
-
susanne beckerSNSFCompletedLow Back Pain | Pain, Acute | Pain, ChronicSwitzerland
-
Universitat Jaume ICompletedPain, Acute | Pain, Chronic | OncologySpain
-
University Hospital Schleswig-HolsteinZealand University Hospital; European Regional Development Fund; Design School...CompletedPain, Acute | Pain, Chronic | Pain Measurement | Pain, CancerGermany
-
Cairo UniversityCompletedCervical Pain | Lumbar Pain SyndromeEgypt
Clinical Trials on Virtual Reality (VR) Mindful App
-
Ohio State UniversityCompletedStress, PhysiologicalUnited States
-
National Institute of Mental Health, Czech RepublicCharles University, Czech Republic; Motol University HospitalCompletedLife Threatening Diseases | Pediatric Palliative Care | Life Limiting ConditionsCzechia
-
Filiz KeskinEnrolling by invitationPregnancy | Sleep Quality | Comfort | Nausea and Vomiting in Pregnancy (NVP)Turkey (Türkiye)
-
University Health Network, TorontoMichael Garron Hospital; Centre for Aging and Brain Health InnovationTerminatedDementia | Delirium Superimposed on DementiaCanada
-
University of MiamiEnrolling by invitation
-
University of California, Los AngelesCompleted
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityCompletedHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid NeoplasmUnited States
-
University of California, Los AngelesRecruiting
-
Sultan Qaboos UniversityNot yet recruitingStroke Patients
-
Eastern Mediterranean UniversityCompleted